Haematopoietic stem cell transplantation in systemic sclerosis

Three randomised controlled trials of haematopoietic stem cell transplantation (HSCT) in systemic sclerosis (SSc) demonstrated long-term survival benefits, induction of clinically meaningful, sustained improvement of forced vital capacity with improvements in skin thickening, vasculopathy and health...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Ulrich A, Saketkoo, Lesley Ann, Distler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045702/
https://www.ncbi.nlm.nih.gov/pubmed/30018796
http://dx.doi.org/10.1136/rmdopen-2017-000533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045702/
https://www.ncbi.nlm.nih.gov/pubmed/30018796
http://dx.doi.org/10.1136/rmdopen-2017-000533

Ejemplares similares